C/ebpα controls osteoclast terminal differentiation, activation, function, and postnatal bone homeostasis through direct regulation of Nfatc1.
C/ebpα controls osteoclast terminal differentiation, activation, function, and postnatal bone homeostasis through direct regulation of Nfatc1.
复制标题
DOI:
10.1002/path.5001
复制
发表时间:
2018-03
期刊:
影响因子:
--
通讯作者:
Li YP
中科院分区:
文献类型:
--
作者:
Chen W;Zhu G;Tang J;Zhou HD;Li YP
Osteoclast lineage commitment and differentiation have been studied extensively, although the mechanism by which transcription factor(s) control osteoclast terminal differentiation, activation and function remains unclear. CCAAT/enhancer-binding protein α (C/ebpα) has been reported to be a key regulator of osteoclast cell lineage commitment, yet C/ebpα’s roles in osteoclast terminal differentiation, activation and function and bone homeostasis, under physiological or pathological conditions, have not been studied because newborn C/ebpα null mice die within several hours after birth. Furthermore, the function of C/ebpα in osteoclast terminal differentiation, activation and function are largely unknown. Herein, we generated and analyzed an osteoclast-specific C/ebpα conditional knockout (CKO) mouse model via Ctsk-Cre mice and found that C/ebpα-deficient mice exhibited a severe osteopetrosis phenotype due to impaired osteoclast terminal differentiation, activation and function, including mildly reduced osteoclast number, impaired osteoclast polarization, actin formation, and bone resorption, which demonstrated the novel function of C/ebpα in cell function and terminal differentiation. Interestingly, C/ebpα deficiency did not affect bone formation or monocyte/macrophage development. Our results further demonstrated that C/ebpα deficiency suppressed the expression of osteoclast functional genes, e.g. encoding Cathepsin K (Ctsk), Atp6i (Tcirg1) and osteoclast regulator genes, e.g. encoding c-fos (Fos), and nuclear factor of activated T-cells 1 (Nfatc1), while having no effect on Pu.1 (Spi1) expression. Promoter activity mapping and ChIP assay defined the critical cis-regulatory element (CCRE) in the promoter region of Nfatc1, and also showed that the CCREs were directly associated with C/ebpα, which enhanced the promoter’s activity. The deficiency of C/ebpα in osteoclasts completely blocked ovariectomy-induced bone loss, indicating C/ebpα is a promising new target for the treatment of osteolytic diseases.
登录
查看更多内容
DOI:
10.1073/pnas.0711961105
发表时间:
2008-04-22
影响因子:
11.1
作者:
Feng, Ru;Desbordes, Sabrina C.;Graf, Thomas
通讯作者:
Graf, Thomas
DOI:
10.1152/ajpgi.00041.2010
发表时间:
2011-04-01
影响因子:
4.5
作者:
Allaire, Joannie M.;Darsigny, Mathieu;Perreault, Nathalie
通讯作者:
Perreault, Nathalie
DOI:
10.1073/pnas.1211383110
发表时间:
2013-04-30
影响因子:
11.1
作者:
Chen, Wei;Zhu, Guochun;Li, Yi-Ping
通讯作者:
Li, Yi-Ping
影响因子:
2.1
作者:
Friedman AD
通讯作者:
Friedman AD
影响因子:
2.3
作者:
Friedman, Alan D.
通讯作者:
Friedman, Alan D.